In vivo molecular imaging of epidermal growth factor receptor in patients with colorectal neoplasia using confocal laser endomicroscopy

Cancer Letters

Volumn 330, Issue 2, 2013, Pages 200-207

  Liu, Jun ^a   Zuo, Xiuli ^a   Li, Changqing ^a   Yu, Tao ^a   Gu, Xiaomeng ^a   Zhou, Chengjun ^b   Li, Zhen ^a   Goetz, Martin ^c   Kiesslich, Ralf ^c   Li, Yanqing ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Colorectal neoplasia; Confocal endomicroscopy; Endoscopy; Epidermal growth factor receptor; Molecular imaging

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL TUMOR; COMPARATIVE STUDY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; FLUORESCENCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MALE; MOLECULAR IMAGING; MOLECULAR PROBE; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; MOLECULAR IMAGING; PILOT PROJECTS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

RODENTIA;

EID: 84873096517     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.11.044     Document Type: Article

References (36)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
2. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767.
3. Tezuka F., Chiba R., Iwama N., Takahashi T. Development of the human colonic adenocarcinoma from adenoma as a histopathologically continuous process. Tohoku J. Exp. Med. 1992, 168:257-263.
4. Vogelstein B., Fearon E.R., Hamilton S.R., Kern S.E., Preisinger A.C., Leppert M., Nakamura Y., White R., Smits A.M., Bos J.L. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 1988, 319:525-532.
5. Cowley G.P., Smith J.A., Gusterson B.A. Increased EGF receptors on human squamous carcinoma cell lines. Br. J. Cancer 1986, 53:223-229.
6. Ciardiello F., Tortora G. A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clin. Cancer Res. 2001, 7:2958-2970.
7. Jaszewski R., Levi E., Sochacki P., Frank J., Kucuk O., Axelrod B.N., Majumdar A.P. Expression of epidermal growth factor-receptor related protein (ERRP) in human colorectal carcinogenesis. Cancer Lett. 2004, 213:249-255.
8. Kaklamanis L., Gatter K.C., Mortensen N., Harris A.L. Interleukin-4 receptor and epidermal growth factor receptor expression in colorectal cancer. Br. J. Cancer 1992, 66:712-716.
9. Han Y.D., Hong Y.K., Kang J.G., Choi Y.J., Park C.H. Relation of the expression of cyclooxygenase-2 in colorectal adenomas and adenocarcinomas to angiogenesis and prognosis. J. Korean Soc. Coloproctol. 2010, 26:339-346.
10. Porebska I., Harlozińska A., Bojarowski T. Expression of the tyrosine kinase activity growth factor receptors (EGFR, ERB B2, ERB B3) in colorectal adenocarcinomas and adenomas. Tumour Biol. 2000, 21:105-115.
11. Salomon D.S., Brandt R., Ciardiello F., Normanno N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. Hematol. 1995, 19:183-232.
12. Rego R.L., Foster N.R., Smyrk T.C., Le M., O'Connell M.J., Sargent D.J., Windschitl H., Sinicrope F.A. Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status. Br. J. Cancer 2010, 102:165-172.
13. Spano J.P., Lagorce C., Atlan D., Milano G., Domont J., Benamouzig R., Attar A., Benichou J., Martin A., Morere J.F., Raphael M., Penault-Llorca F., Breau J.L., Fagard R., Khayat D., Wind P. Impact of EGFR expression on colorectal cancer patient prognosis and survival. Ann. Oncol. 2005, 16:102-108.
14. Hemming A.W., Davis N.L., Kluftinger A., Robinson B., Quenville N.F., Liseman B., LeRiche J. Prognostic markers of colorectal cancer: an evaluation of DNA content, epidermal growth factor receptor, and Ki-67. J. Surg. Oncol. 1992, 51:147-152.
15. Cunningham D., Humblet Y., Siena S., Khayat D., Bleiberg H., Santoro A., Bets D., Mueser M., Harstrick A., Verslype C., Chau I., Van Cutsem E. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N. Engl. J. Med. 2004, 351:337-345.
16. Chung K.Y., Shia J., Kemeny N.E., Shah M., Schwartz G.K., Tse A., Hamilton A., Pan D., Schrag D., Schwartz L., Klimstra D.S., Fridman D., Kelsen D.P., Saltz L.B. Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry. J. Clin. Oncol. 2005, 23:1803-1810.
17. Saltz L. Epidermal growth factor receptor-negative colorectal cancer: is there truly such an entity?. Clin. Colorectal. Cancer 2005, (Suppl. 2):S98-100.
18. Hamilton S.R. Targeted therapy of cancer: new roles for pathologists in colorectal cancer. Mod. Pathol. 2008, 21:S23-30.
19. Rex D.K., Cutler C.S., Lemmel G.T., Rahmani E.Y., Clark D.W., Helper D.J., Lehman G.A., Mark D.G. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997, 112:24-28.
20. Goetz M., Wang T.D. Molecular imaging in gastrointestinal endoscopy. Gastroenterology 2010, 138:828-833.
21. Goetz M., Ziebart A., Foersch S., Vieth M., Waldner M.J., Delaney P., Galle P.R., Neurath M.F., Kiesslich R. In vivo molecular imaging of colorectal cancer with confocal endomicroscopy by targeting epidermal growth factor receptor. Gastroenterology 2010, 138:435-446.
22. Foersch S., Kiesslich R., Waldner M.J., Delaney P., Galle P.R., Neurath M.F., Goetz M. Molecular imaging of VEGF in gastrointestinal cancer in vivo using confocal laser endomicroscopy. Gut 2010, 59:1046-1055.
23. Hsiung P.L., Hardy J., Friedland S., Soetikno R., Du C.B., Wu A.P., Sahbaie P., Crawford J.M., Lowe A.W., Contag C.H., Wang T.D. Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy. Nat. Med. 2008, 14:454-458.
24. Nakai Y., Shinoura S., Ahluwalia A., Tarnawski A.S., Chang K.J. Molecular imaging of epidermal growth factor-receptor and survivin in vivo in porcine esophageal and gastric mucosae using probe-based confocal laser-induced endomicroscopy: proof of concept. J. Physiol. Pharmacol. 2012, 63:303-307.
25. Schlemper R.J., Riddell R.H., Kato Y., Borchard F., Cooper H.S., Dawsey S.M., Dixon M.F., Fenoglio-Preiser C.M., Fléjou J.F., Geboes K., Hattori T., Hirota T., Itabashi M., Iwafuchi M., Iwashita A., Kim Y.I., Kirchner T., Klimpfinger M., Koike M., Lauwers G.Y., Lewin K.J., Oberhuber G., Offner F., Price A.B., Rubio C.A., Shimizu M., Shimoda T., Sipponen P., Solcia E., Stolte M., Watanabe H., Yamabe H. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000, 47:251-255.
26. Keller R., Winde G., Terpe H.J., Foerster E.C., Domschke W. Fluorescence endoscopy using a fluorescein-labeled monoclonal antibody against carcinoembryonic antigen in patients with colorectal carcinoma and adenoma. Endoscopy 2002, 34:801-817.
27. Mariotte D., Dupont B., Gervais R., Galais M.P., Laroche D., Tranchant A., Comby E., Bouhier-Leporrier K., Reimund J.M., Le Mauff B. Anti-cetuximab IgE ELISA for identification of patients at a high risk of cetuximab-induced anaphylaxis. MAbs 2011, 3:396-401.
28. Jonker D.J., O'Callaghan C.J., Karapetis C.S., Zalcberg J.R., Tu D., Au H.J., Berry S.R., Krahn M., Price T., Simes R.J., Tebbutt N.C., van Hazel G., Wierzbicki R., Langer C., Moore M.J. Cetuximab for the treatment of colorectal cancer. N. Engl. J. Med. 2007, 357:2040-2048.
29. Atkins D., Reiffen K.A., Tegtmeier C.L., Winther H., Bonato M.S., Storkel S. Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues: variation in staining intensity due to choice of fixative and storage time of tissue sections. J. Histochem. Cytochem. 2004, 52:893-901.
30. Goldstein N.S., Armin M. Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma: implications for a standardized scoring system. Cancer 2001, 92:1331-1346.
31. Atreya R., Waldner M.J., Neurath M.F. Molecular imaging: interaction between basic and clinical science. Gastroenterol. Clin. North Am. 2010, 39:911-922.
32. Alencar H., Funovics M.A., Figueiredo J., Sawaya H., Weissleder R., Mahmood U. Colonic adenocarcinomas: near-infrared microcatheter imaging of smart probes for early detection-study in mice. Radiology 2007, 244:232-238.
33. Zhang H., Morgan D., Cecil G., Burkholder A., Ramocki N., Scull B., Lund P.K. Biochromoendoscopy: molecular imaging with capsule endoscopy for detection of adenomas of the GI tract. Gastrointest. Endosc. 2008, 68:520-527.
34. Goldstein N.S., Armin M. Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on cancer stage IV colon adenocarcinoma. Cancer 2001, 92:1331-1346.
35. Deane N.G., Manning H.C., Foutch A.C., Washington M.K., Aronow B.J., Bornhop D.J., Coffey R.J. Targeted imaging of colonic tumors in smad3-/- mice discriminates cancer and inflammation. Mol. Cancer Res. 2007, 5:341-349.
36. Gong H., Kovar J., Little G., Chen H., Olive D.M. In vivo imaging of xenograft tumors using an epidermal growth factor receptor-specific affibody molecule labeled with a near-infrared fluorophore. Neoplasia 2010, 12:139-149.